Einzeltreffer — DigiBib

Background: Adenosinergic system has been implicated in the pathophysiology of bipolar disorder and drugs that affect adenosine neurotransmission have shown some efficacy as add-on therapy in manic patients.

Objective: Thus, the aim of the present study was to screen adenosinergic drugs for antimanic-like effect in methylphenidate (MPH)-induced hyperlocomotion in mice.

Methods: Male and female Swiss mice received a single allopurinol (50 and 200 mg/kg, ip), dipyridamole (20 mg/kg, ip), or inosine (50 mg/kg, ip) administration before an acute MPH challenge (5 mg/kg, sc). In experiments with repeated treatment, male mice received a daily administration of allopurinol (25 and 50 mg/kg, ip), dipyridamole (20 mg/kg, ip), or inosine (50 mg/kg, ip) for 14 days. Finally, pretreatment with aminophylline (2 mg/kg, sc), an unspecific adenosine receptor antagonist, was used to evaluate a putative adenosinergic mediation. Locomotor activity was measured in the automated activity chamber for 20 min.

Results: Acute and repeated dipyridamole reduced the increase in locomotor activity induced by MPH, while allopurinol and inosine had no effect. Aminophylline blocked the effect of dipyridamole in MPH-induced hyperlocomotion.

Conclusion: The present results suggest that dipyridamole may have an antimanic-like effect through adenosine receptors and reinforce the proposal that the adenosine system may be an interesting target for new antimanic drugs.

Titel:	Antimanic-like effect of dipyridamole in the methylphenidate-induced hyperlocomotion.
Autor/in / Beteiligte Person:	Santos, AG ; Kühl, CE ; Higashijima, AN ; Kanazawa, LKS ; de Souza STF ; Andreatini, R
Link:	Full Text Finder (Volltext)
Zeitschrift:	Fundamental & clinical pharmacology, 2024-03-12
Veröffentlichung:	Ahead of Print, 2024
Medientyp:	academicJournal
ISSN:	1472-8206 (electronic)
DOI:	10.1111/fcp.13001
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [Fundam Clin Pharmacol] 2024 Mar 12. <i>Date of Electronic Publication: </i>2024 Mar 12. References: Salvadore G, Viale CI, Luckenbaugh DA, et al. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):819-821. doi:10.1016/j.pnpbp.2010.02.027. ; Bartoli F, Crocamo C, Dakanalis A, et al. Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study. Compr Psychiatry. 2017;73:1-6. doi:10.1016/j.comppsych.2016.09.011. ; Akhondzadeh S, Milajerdi MR, Amini H, Tehrani-Doost M. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Bipolar Disord. 2006;8(5 Pt 1):485-489. doi:10.1111/j.1399-5618.2006.00363.x. ; Machado-Vieira R, Soares JC, Lara DR, et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry. 2008;69(8):1237-1245. doi:10.4088/jcp.v69n0806. ; Jahangard L, Soroush S, Haghighi M, et al. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Eur Neuropsychopharmacol. 2014;24(8):1210-1221. doi:10.1016/j.euroneuro.2014.05.013. ; Bartoli F, Cavaleri D, Bachi B, et al. Repurposed drugs as adjunctive treatments for mania and bipolar depression: a meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. J Psychiatr Res. 2021;143:230-238. doi:10.1016/j.jpsychires.2021.09.018. ; Weiser M, Burshtein S, Gershon AA, et al. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Bipolar Disord. 2014;16(4):441-447. doi:10.1111/bdi.12202. ; Camerini L, Ardais AP, Xavier J, et al. Inosine prevents hyperlocomotion in a ketamine-induced model of mania in rats. Brain Res. 2020;1733:146721. doi:10.1016/j.brainres.2020.146721. ; Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(2):209-224. doi:10.1016/j.pnpbp.2003.10.015. ; Young JW, Henry BL, Geyer MA. Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol. 2011;164(4):1263-1284. doi:10.1111/j.1476-5381.2011.01318.x. ; de Miranda AS, Andreatini R, Teixeira AL. Animal models of mania: essential tools to better understand bipolar disorder. In: Michael Conn P, ed. Animal Models for the Study of Human Disease. 2nd ed. Academic Press, 10.1016/B978-0-12-809468-6.00043-7; 2017:1131-1143. ; Gonçalves FM, Neis VB, Rieger DK, et al. Signaling pathways underlying the antidepressant-like effect of inosine in mice. Purinergic Signal. 2017;13(2):203-214. doi:10.1007/s11302-016-9551-2. ; Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behav Genet. 2007;37(1):244-255. doi:10.1007/s10519-006-9093-4. ; Wendler E, de Souza CP, Vecchia DD, et al. Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: ketamine and lisdexamfetamine-induced hyperlocomotion in rats. Eur Neuropsychopharmacol. 2016;26(12):1900-1908. doi:10.1016/j.euroneuro.2016.10.012. ; Barbosa FJ, Hesse B, de Almeida RB, Baretta IP, Boerngen-Lacerda R, Andreatini R. Magnesium sulphate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania. Pharmacol Rep. 2011;63(1):64-70. doi:10.1016/s1734-1140(11)70399-1. ; Pereira M, Martynhak BJ, Baretta IP, Correia D, Siba IP, Andreatini R. Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphene. Neurosci Lett. 2011;500(2):95-98. doi:10.1016/j.neulet.2011.06.012. ; Tonelli DA, Pereira M, Siba IP, et al. The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels. Fundam Clin Pharmacol. 2013;27(6):650-655. doi:10.1111/fcp.12022. ; Arunagiri P, Rajeshwaran K, Shanthakumar J, Balamurugan E. Supplementation of omega-3 fatty acids with aripiprazole and lithium lessens methylphenidate induced manic behavior in Swiss albino mice. PharmaNutrition. 2014;2(1):26-32. doi:10.1016/j.phanu.2013.11.128. ; Nogoceke FP, Barcaro IM, de Sousa DP, Andreatini R. Antimanic-like effects of (R)-(−)-carvone and (S)-(+)-carvone in mice. Neurosci Lett. 2016;619:43-48. doi:10.1016/j.neulet.2016.03.013. ; Kanazawa LK, Vecchia DD, Wendler EM, et al. Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress. Life Sci. 2017;171:1-8. doi:10.1016/j.lfs.2017.01.007. ; Asth L, Tiago PRF, Costa LRF, et al. Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: implications for bipolar disorders. Neuropeptides. 2020;82:102059. doi:10.1016/j.npep.2020.102059. ; Gonçalves PS, Pesquero BO, Valentin DT, Monteiro Pereira VC, Andreatini R. Effect of repeated sodium valproate and topiramate administration on mania-like behaviors induced by methylphenidate in mice. Acta Neurobiol Exp (Wars). 2022;82(4):511-520. doi:10.55782/ane-2022-049. ; Smith RC, Davis JM. Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology (Berl). 1977;53(1):1-12. doi:10.1007/BF00426687. ; Viktorin A, Rydén E, Thase ME, et al. The risk of treatment-emergent mania with methylphenidate in bipolar disorder. Am J Psychiatry. 2017;174(4):341-348. doi:10.1176/appi.ajp.2016.16040467. ; Katsuragi T, Ushijima I, Furukawa T. The clonidine-induced self-injurious behavior of mice involves purinergic mechanisms. Pharmacol Biochem Behav. 1984;20(6):943-946. doi:10.1016/0091-3057(84)90020-0. ; Zangrossi H Jr, Leite JR, Graeff FG. Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine. Psychopharmacology (Berl). 1992;106(1):85-89. doi:10.1007/BF02253593. ; Schmidt AP, Böhmer AE, Antunes C, et al. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol. 2009;156(1):163-172. doi:10.1111/j.1476-5381.2008.00025.x. ; Kaster MP, Budni J, Gazal M, Cunha MP, Santos AR, Rodrigues AL. The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A2A receptors. Purinergic Signal. 2013;9(3):481-486. doi:10.1007/s11302-013-9361-8. ; Allahham M, Lerman A, Atar D, Birnbaum Y. Why not dipyridamole: a review of current guidelines and re-evaluation of utility in the modern era. Cardiovasc Drugs Ther. 2022;36(3):525-532. doi:10.1007/s10557-021-07224-9. ; Fujiwara Y, Sato M, Otsuki S. Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors. Psychopharmacology (Berl). 1986;90(3):332-335. doi:10.1007/BF00179186. ; Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord. 2006;8(3):275-280. doi:10.1111/j.1399-5618.2006.00318.x. ; Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Dipyridamole: a drug with unrecognized antioxidant activity. Curr Top Med Chem. 2015;15(9):822-829. doi:10.2174/1568026615666150220111942. ; Hodes A, Lifschytz T, Rosen H, Cohen Ben-Ami H, Lichtstein D. Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine. Brain Res Bull. 2018;137:356-362. doi:10.1016/j.brainresbull.2018.01.016. ; Ghanaatfar F, Ghanaatfar A, Isapour P, et al. Is lithium neuroprotective? An updated mechanistic illustrated review. Fundam Clin Pharmacol. 2023;37(1):4-30. doi:10.1111/fcp.12826. ; Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB j. 2008;22(3):659-661. doi:10.1096/fj.07-9574LSF. ; da Silva RB, Siebel AM, Bonan CD. The role of purinergic and dopaminergic systems on MK-801-induced antidepressant effects in zebrafish. Pharmacol Biochem Behav. 2015;139(Pt B):149-157. doi:10.1016/j.pbb.2015.05.005. ; Karve AV, Jagtiani SS, Chitnis KA. Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice. Indian J Pharm. 2013;45(3):244-247. doi:10.4103/0253-7613.111922. ; Ayyar P, Ravinder JR. Animal models for the evaluation of antipsychotic agents. Fundam Clin Pharmacol. 2023;37(3):447-460. doi:10.1111/fcp.12855. Grant Information: 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Conselho Nacional de Desenvolvimento Científico e Tecnológico Contributed Indexing: Keywords: adenosine; allopurinol; animal model; inosine; mania Entry Date(s): Date Created: 20240312 Latest Revision: 20240312 Update Code: 20240313

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Antimanic-like effect of dipyridamole in the methylphenidate-induced hyperlocomotion.